P-204 - A RANDOMIZED PHASE 1 STUDY EVALUATING THE PHARMACOKINETIC EQUIVALENCE OF PROPOSED BIOSIMILAR HLX14 AND DENOSUMAB IN HEALTHY CHINESE VOLUNTEERS.
J. Zhang1, X. Wu1, X. Zhang2, L. Zhou2, W. Kang2, J. Zhu2; 1Huashan Hospital, Fudan University, Shanghai, China, 2Shanghai Henlius Biotech, Inc., Shanghai, China.
.jpg "Jing Zhang, MD, PhD photo")
.png)